Background With a universal shortage of donor organs, screening and selection of marginal kidneys from non-heart-beating donors (NHBDs) provides a valuable source for transplantation. Pre-transplant viability assessment is based on a combination of flow characteristics and assessment of ischaemic tissue injury during NHBD kidney machine perfusion by measurement of total glutathione S-transferase (GST) activity. Successful viability screening has facilitated 69 renal transplants from 60 NHBDs within our transplant centre since 1998, with a first-year graft survival of 90 ¢ 5%.
Introduction
The increasing shortfall in the availability of donor organs for transplantation has led to a renewed interest in non-heart-beating donors (NHBDs) as a potential source of transplantable kidneys. It has been estimated that the UK donor pool could be increased by 20 -45% by the universal inclusion of NHBDderived kidneys. 1 However, a major problem with the use of such kidneys is the inevitable tissue damage sustained from periods of warm ischaemia, although the advantages of hypothermic machine perfusion of kidneys in preventing the latter process have been discussed. 2 Thus the success of NHBD renal transplants depends on the e¤cacy of pre-transplant organ preservation and viability assessment, a key factor of which involves the measurement of biochemical markers of tissue injury in the kidney perfusate. Although a number of such parameters have been investigated with mixed success, the quanti¢cation of the enzyme glutathione S-transferase (GST) (EC 2.5.1.18) is currently regarded as the most promising. However, there is still no totally reliable biochemical marker to di¡erentiate viable and non-viable kidneys. 3 The objective of the present investigation was to assess the ability of two novel potential biochemical markers, alanine aminopeptidase (Ala-AP) 4 (EC 3.4.11.14) and fatty acid binding protein (FABP), 5 to indicate renal tissue injury and to compare this with the performance of the more routinely established biochemical marker, GST, in machine perfusion pretransplant.
The measurement of Ala-AP in urine as an index of tissue damage in renal disease has been described previously, including the assessment of kidney function post-transplant. 4, 6, 7 However, with the exception of the preliminary report by Balupuri et al., 2 the use of Ala-AP as a potential biochemical marker of tissue injury in human NHBD kidneys prior to transplant has not been described. Although FABP has been reported as a sensitive biochemical marker of myocardial damage following myocardial infarction, it has not been previously investigated as a marker of tissue injury in NHBD kidneys.
Materials and methods

Donor kidneys
NHBD kidneys (n=120) were procured from 60 donors, based on established criteria. 8 Maastricht category II (uncontrolled) donors were referred from the local accident and emergency department, following cardiac arrest that was unresponsive to cardiopulmonary resuscitation. Maastricht category III (controlled) donors were referred from intensive care units following`withdrawal of supportive therapy' (see Table 1 ). Uncontrolled donor kidneys predominately had longer primary warm ischaemic times and therefore greater ischaemic insult than controlled donor kidneys.
In all cases, a bolus of 25 000 IU of heparin was administered systemically (immediately prior to declaration of death) and a femoral cut-down performed to insert a double -balloon triple-lumen catheter into the aorta, through which 20 L of heparinized (5000 IU/L) preservation £uid (Marshall's solution) was perfused. After retrieval, the kidneys were machine perfused for 4-8 h using the Newcastle hypothermic preservation system, primed with 500 mL of modi¢ed University of Wisconsin organ preservation solution. 9,10 A variety of parameters, including temperature, £ow rate, perfusion pressure and perfusion resistance, were measured on samples of e¥uent taken on an hourly basis. In total, ¢ve perfusates were collected for each donor kidney: a preperfusion sample and four samples up to 4 h of perfusion. The GST activity in the perfusate was determined in`real time' following prior arrangement with the Biochemistry Department. Further perfusate samples were taken and immediately frozen at 7208C for subsequent analysis of Ala-AP and FABP.
Measurement of biochemical markers
GST activity in kidney perfusate samples was determined using a Cobas Mira analyser (Dade Behring, Belgium) and a modi¢cation of the method of Habig and Jakoby, based on the monitoring at 340 nm of the conjugation of chlorodinitrobenzene with glutathione at 258C to form glutathione S-dinitrobenzene. 11 An aqueous solution of ischaemic renal tissue (standard Maastricht GST solution) was used to construct the calibration curve for this assay.
Ala-AP activity was measured using a speci¢c £uorimetric assay as previously described. 12 Brie£y, perfusate samples (50 mL) were incubated for 10 min with the appropriate assay medium (total volume 300 mL) at 378C; the reaction was terminated by the addition of 600 mL of ethanol. Following cleavage of the substrate [alanine 7-amido-4-methyl coumarin (AMC)], the £uorescence of the liberated AMC was measured by reference to a tetraphenylbutadiene £uorescence standard (l ex =380 nm, l em =440 nm). Assay blanks were run in which the enzyme sample was added to the medium immediately after termination with ethanol. Assay conditions were modi¢ed for samples with high activity such that the extent of substrate utilization never exceeded 15%.
Heart-type FABP (h-FABP) was assayed using a sandwich ELISA assay. 13 Brie£y, a microtitre plate was coated with a primary monoclonal detector antibody, then, after incubation with plasma and horseradish-peroxidase-labelled detector antibody, tetramethylbenzidine was added. The reaction was stopped with sulphuric acid before detection at 450 nm using calibration via recombinant h-FABP. 14 All biochemical marker results were corrected for 100 g kidney tissue mass.
Statistical analysis
Statistical evaluation of data between groups of NHBD kidneys (i.e. transplanted versus discarded; controlled versus uncontrolled) was performed using the Mann-Whitney U-test, with P50 ¢05 as the level of signi¢cance. The relationship between the GST/Ala-AP and GST/FABP scatter diagram data was investigated by determining the Spearman rank correlation coe¤cient (r). Measurements were performed on all perfusates whether or not the kidney was used or discarded.
Results
The perfusate levels of GST, Ala-AP and FABP increased from time T0, reaching plateau around times T3 and T4 (see Fig. 1 ). A parallel response is seen for all three markers in perfusates of controlled and uncontrolled donors, being low in the optimal kidneys (controlled donors). The di¡erences between the donor groups are especially notable at time T4. A similar pattern is observed for the transplanted and discarded kidneys although only GST was used in the viability assessment (see Fig. 2 ). Spearman rank correlation coe¤cient (r) is higher for FABP than for Ala-AP. NHBD kidneys of optimal viability as in the controlled and transplanted group have lower paired values, which can be clearly identi-¢ed in the plots.
Discussion
With the increased shortage of suitable donors, there has been renewed interest in marginal donors. This means that viability testing, which was previously not considered essential with NHBDs, is vital. An essential component in viability assessment is the analysis of suitable biochemical markers of tissue injury in machine perfusates pre-transplant.
During ischaemia there is release of cytoplasmic contents of damaged cells into the interstitial and intravascular space. Although the measurement of GST activity in machine perfusion is an accepted viability criterion, failure to identify defective kidneys results in a primary non-function rate of 6-12% in NHBD renal transplants. 15, 16 In addition, overcautious disquali¢cation of presumed non-viable kidneys has been estimated to result in a discard rate of 9-34% of total procured NHBD kidneys. 16, 17 A number of factors may determine the e¤cacy of intracellular proteins or enzymes as potential markers of renal tissue injury (e.g. tissue concentration, intracellular localization, function, molecular size, (Mann-Whitney U-test) for all three biochemical markers for transplanted (-, n=69) and discarded (---, n=51) non-heart-beating donor (NHBD) kidneys. extracellular stability). GST is a microsomal enzyme with a wide tissue distribution. It takes part in detox-i¢cation reactions via conjugation of metabolites with glutathione. 18 Its use in transplant viability assessment was investigated in the late 1970s. 19 Two renal iso-enzymes of GST have been identi¢ed, a-GST and p-GST, which are located in the proximal and distal tubules, respectively. Tissue damage resulting from prolonged warm ischaemia results in the release of a-GST and the usefulness of this parameter as a predictor of NHBD renal transplant outcome has been reported. 3 More recently, Balupuri et al. compared the relative merits of total GST and a-GST as markers of NHBD renal tissue injury. 20 Ala-AP is an exopeptidase (molecular mass approximately 100 kDa) that is located in the cytosol and plasma membrane of various tissues and is thought to be involved both in the generalized process of intracellular protein turnover as well as in the regulation of physiologically active peptides. 21, 22 The measurement of urinary Ala-AP as an index of tissue damage in renal disease has been described previously. 6 FABP is a transport protein (molecular mass approximately 15 kDa) that is involved in the translocation of long-chain fatty acids from the cytoplasm to their site of b-oxidation in the mitochondria. Serum h-FABP has been reported to be a sensitive and quantitative biochemical marker of myocardial injury following myocardial infarction. 23, 24 In the renal parenchyma, two isoforms, h-FABP and liver-type (l-FABP), have been located in the distal and proximal renal tubules, respectively. 25, 26 h-FABP is reported to be released early on following renal ischaemic injury. Thus the rationale for the comparative investigation of GST, Ala-AP and FABP as potential biochemical markers of tissue injury in NHBD kidneys depends on their relative di¡erences in intracellular localization, function and molecular mass, together with the precedent for their use as tissue injury biochemical markers in other disorders as noted above.
In the present investigation, the activities of GST (see Fig. 1a ) and Ala-AP (see Fig. 1b ) and the concentration of FABP (see Fig. 1c ) showed similar increases in NHBD kidney perfusates over the 4-h machine perfusion period. The activities of each marker (see Fig. 2a points) in discarded versus transplanted kidneys. Combining all of the above data (i.e. from controlled/ uncontrolled categories and transplant/discarded kidneys) revealed a highly signi¢cant correlation between corresponding activities of GST and Ala-AP (r=0¢7859, P50 ¢0001) and of GST and FABP (r=0¢8843, P50 ¢0001). FABP shows a better correlation than Ala-AP and this is re£ected in the r value (see Fig. 3 ). It is therefore concluded that GST, Ala-AP and FABP represent equivalent biochemical markers in terms of their ability to quantitate renal tissue injury in human NHBD kidneys. In practice, there may be some advantage in using all three markers, with Ala-AP and FABP providing additional complementary information to the standard GST measurement. The relative costs of the three assays are detailed in Table 2 . However, it must be emphasized that any marker selected to assess tissue injury is only one component of a multi-parameter screening protocol within the Newcastle Transplant Unit. Other criteria include donor age, donor medical history, macroscopic appearance, warm ischaemic time and ex vivo perfusion. 27 
